MEDFX Trademark

Trademark Overview

On Thursday, March 13, 2014, a trademark application was filed for MEDFX with the United States Patent and Trademark Office. The USPTO has given the MEDFX trademark a serial number of 86220538. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, July 14, 2025. This trademark is owned by Boston Research & Development, LLC. The MEDFX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes
medfx

General Information

Serial Number86220538
Word MarkMEDFX
Filing DateThursday, March 13, 2014
Status800 - REGISTERED AND RENEWED
Status DateMonday, July 14, 2025
Registration Number4842066
Registration DateTuesday, October 27, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 22, 2014

Trademark Statements

Goods and ServicesPharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes
Pseudo MarkMED FX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 27, 2014
Primary Code005
First Use Anywhere DateThursday, August 15, 2013
First Use In Commerce DateThursday, August 15, 2013

Trademark Owner History

Party NameBoston Research & Development, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNorwood, MA 02062
Party NameBoston Research & Development, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorwood, MA 02062
Party NameBoston Research & Development, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorwood, MA 02062

Trademark Events

Event DateEvent Description
Tuesday, July 22, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 17, 2014NEW APPLICATION ENTERED
Thursday, March 27, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 28, 2014NOTICE OF PSEUDO MARK E-MAILED
Tuesday, June 17, 2014ASSIGNED TO EXAMINER
Wednesday, June 18, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 2, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 22, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 23, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 16, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 12, 2015SOU TEAS EXTENSION RECEIVED
Thursday, March 12, 2015SOU EXTENSION 1 FILED
Thursday, March 12, 2015SOU EXTENSION 1 GRANTED
Saturday, March 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 9, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, September 9, 2015USE AMENDMENT FILED
Monday, September 21, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 24, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 27, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, October 27, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 27, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 29, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, February 12, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, October 28, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, July 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 14, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, July 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, July 14, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Related Keywords

medfx pain cancer diseases metabolic neurodegenerative disorders psychiatric illnesses symptoms from